Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax

Lisa Winterroth, Johanna Rivera, Antonio S. Nakouzi, Ekaterina Dadachova, Arturo Casadevall

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Edema factor (EF) is a component of an anthrax toxin that functions as an adenylate cyclase. Numerous monoclonal antibodies (MAbs) have been reported for the other Bacillus anthracis toxin components, but relatively few to EF have been studied. We report the generation of six murine hybridoma lines producing two IgM and four IgG1 MAbs to EF. Of the six MAbs, only one IgM neutralized EF, as assayed by an increase in cyclic AMP (cAMP) production by Chinese hamster ovary (CHO) cells. Analysis of the variable gene elements revealed that the single neutralizing MAb had a different binding site than the others. There was no competition between the neutralizing IgM and the nonneutralizing IgG MAbs indicative of different specificity. MAb-based capture enzyme-linked immunosorbent assay (ELISA) detected EF in liver lysates from mice infected with B. anthracis Sterne 34F2. Administration of the neutralizing IgM MAb to A/JCr mice lethally infected with B. anthracis strain Sterne had no significant effect on median time to death, but mice treated with the MAb were more likely to survive infection. Combining the neutralizing IgM to EF with a subprotective dose of a neutralizing MAb to protective antigen (PA) prolonged mean time to death of infected mice, suggesting that neutralization of EF and PA could produce synergistic beneficial effects. In summary, the results from our study and literature observations suggest that the majority of Abs to EF are nonneutralizing, but the toxin has some epitopes that can be targeted by the humoral response to generate useful Abs that may contribute to defense against anthrax.

Original languageEnglish (US)
Pages (from-to)2890-2898
Number of pages9
JournalInfection and Immunity
Volume78
Issue number6
DOIs
StatePublished - Jun 2010

Fingerprint

Anthrax
Neutralizing Antibodies
Edema
Monoclonal Antibodies
Immunoglobulin M
Bacillus anthracis
Immunoglobulin G
Antigens
edema factor
Hybridomas
Cricetulus
Adenylyl Cyclases
Cyclic AMP
Epitopes
Ovary
Enzyme-Linked Immunosorbent Assay
Binding Sites
Liver
Infection

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Parasitology
  • Infectious Diseases

Cite this

Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax. / Winterroth, Lisa; Rivera, Johanna; Nakouzi, Antonio S.; Dadachova, Ekaterina; Casadevall, Arturo.

In: Infection and Immunity, Vol. 78, No. 6, 06.2010, p. 2890-2898.

Research output: Contribution to journalArticle

Winterroth, L, Rivera, J, Nakouzi, AS, Dadachova, E & Casadevall, A 2010, 'Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax', Infection and Immunity, vol. 78, no. 6, pp. 2890-2898. https://doi.org/10.1128/IAI.01101-09
Winterroth, Lisa ; Rivera, Johanna ; Nakouzi, Antonio S. ; Dadachova, Ekaterina ; Casadevall, Arturo. / Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax. In: Infection and Immunity. 2010 ; Vol. 78, No. 6. pp. 2890-2898.
@article{04fd702217e341aabd6457eb96e1f822,
title = "Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax",
abstract = "Edema factor (EF) is a component of an anthrax toxin that functions as an adenylate cyclase. Numerous monoclonal antibodies (MAbs) have been reported for the other Bacillus anthracis toxin components, but relatively few to EF have been studied. We report the generation of six murine hybridoma lines producing two IgM and four IgG1 MAbs to EF. Of the six MAbs, only one IgM neutralized EF, as assayed by an increase in cyclic AMP (cAMP) production by Chinese hamster ovary (CHO) cells. Analysis of the variable gene elements revealed that the single neutralizing MAb had a different binding site than the others. There was no competition between the neutralizing IgM and the nonneutralizing IgG MAbs indicative of different specificity. MAb-based capture enzyme-linked immunosorbent assay (ELISA) detected EF in liver lysates from mice infected with B. anthracis Sterne 34F2. Administration of the neutralizing IgM MAb to A/JCr mice lethally infected with B. anthracis strain Sterne had no significant effect on median time to death, but mice treated with the MAb were more likely to survive infection. Combining the neutralizing IgM to EF with a subprotective dose of a neutralizing MAb to protective antigen (PA) prolonged mean time to death of infected mice, suggesting that neutralization of EF and PA could produce synergistic beneficial effects. In summary, the results from our study and literature observations suggest that the majority of Abs to EF are nonneutralizing, but the toxin has some epitopes that can be targeted by the humoral response to generate useful Abs that may contribute to defense against anthrax.",
author = "Lisa Winterroth and Johanna Rivera and Nakouzi, {Antonio S.} and Ekaterina Dadachova and Arturo Casadevall",
year = "2010",
month = "6",
doi = "10.1128/IAI.01101-09",
language = "English (US)",
volume = "78",
pages = "2890--2898",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax

AU - Winterroth, Lisa

AU - Rivera, Johanna

AU - Nakouzi, Antonio S.

AU - Dadachova, Ekaterina

AU - Casadevall, Arturo

PY - 2010/6

Y1 - 2010/6

N2 - Edema factor (EF) is a component of an anthrax toxin that functions as an adenylate cyclase. Numerous monoclonal antibodies (MAbs) have been reported for the other Bacillus anthracis toxin components, but relatively few to EF have been studied. We report the generation of six murine hybridoma lines producing two IgM and four IgG1 MAbs to EF. Of the six MAbs, only one IgM neutralized EF, as assayed by an increase in cyclic AMP (cAMP) production by Chinese hamster ovary (CHO) cells. Analysis of the variable gene elements revealed that the single neutralizing MAb had a different binding site than the others. There was no competition between the neutralizing IgM and the nonneutralizing IgG MAbs indicative of different specificity. MAb-based capture enzyme-linked immunosorbent assay (ELISA) detected EF in liver lysates from mice infected with B. anthracis Sterne 34F2. Administration of the neutralizing IgM MAb to A/JCr mice lethally infected with B. anthracis strain Sterne had no significant effect on median time to death, but mice treated with the MAb were more likely to survive infection. Combining the neutralizing IgM to EF with a subprotective dose of a neutralizing MAb to protective antigen (PA) prolonged mean time to death of infected mice, suggesting that neutralization of EF and PA could produce synergistic beneficial effects. In summary, the results from our study and literature observations suggest that the majority of Abs to EF are nonneutralizing, but the toxin has some epitopes that can be targeted by the humoral response to generate useful Abs that may contribute to defense against anthrax.

AB - Edema factor (EF) is a component of an anthrax toxin that functions as an adenylate cyclase. Numerous monoclonal antibodies (MAbs) have been reported for the other Bacillus anthracis toxin components, but relatively few to EF have been studied. We report the generation of six murine hybridoma lines producing two IgM and four IgG1 MAbs to EF. Of the six MAbs, only one IgM neutralized EF, as assayed by an increase in cyclic AMP (cAMP) production by Chinese hamster ovary (CHO) cells. Analysis of the variable gene elements revealed that the single neutralizing MAb had a different binding site than the others. There was no competition between the neutralizing IgM and the nonneutralizing IgG MAbs indicative of different specificity. MAb-based capture enzyme-linked immunosorbent assay (ELISA) detected EF in liver lysates from mice infected with B. anthracis Sterne 34F2. Administration of the neutralizing IgM MAb to A/JCr mice lethally infected with B. anthracis strain Sterne had no significant effect on median time to death, but mice treated with the MAb were more likely to survive infection. Combining the neutralizing IgM to EF with a subprotective dose of a neutralizing MAb to protective antigen (PA) prolonged mean time to death of infected mice, suggesting that neutralization of EF and PA could produce synergistic beneficial effects. In summary, the results from our study and literature observations suggest that the majority of Abs to EF are nonneutralizing, but the toxin has some epitopes that can be targeted by the humoral response to generate useful Abs that may contribute to defense against anthrax.

UR - http://www.scopus.com/inward/record.url?scp=77952735635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952735635&partnerID=8YFLogxK

U2 - 10.1128/IAI.01101-09

DO - 10.1128/IAI.01101-09

M3 - Article

C2 - 20385755

AN - SCOPUS:77952735635

VL - 78

SP - 2890

EP - 2898

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 6

ER -